Continuous Glucose Monitoring Device Market Size, Share & Trends Analysis Report 2021-2028
Continuous Glucose Monitoring Device Industry Overview
The global continuous glucose monitoring device market size was valued at USD 4.7 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 10.1% from 2021 to 2028. Key factors driving this market are the rising incidence of diabetes, coupled with the increasing geriatric population prone to diabetes. The Continuous Glucose Monitoring (CGM) devices market is further propelled by growing awareness about diabetes preventive care, new product launches, and supportive government initiatives. Increased demand for continuous glucose monitoring devices amid the COVID-19 pandemic is attributed to the loosened restricted regulations and issued guidelines for the use of home-use glucose meters or CGMs in hospital settings by the federal agencies. The CGMs approved for hospital use include the Dexcom G6 and Abbott FreeStyle Libre.
This was mainly done to ensure the safety of healthcare workers and self-testing among the patients. The American Diabetic Association also issued several resources on COVID-19 and diabetes. Delayed diagnosis due to lockdown restrictions and low awareness among several developing countries are likely to hamper the adoption of these devices. According to the survey conducted by Novartis AG, only 7% of individuals visit doctors at an early or pre-diabetic stage, leaving a staggering 93% with already developed type 2 diabetes. A rise in the incidence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the factors contributing to the growth of the market.
Gather more insights about the market drivers, restrains and growth of the Global Continuous Glucose Monitoring Device market
Obesity is a major factor leading to diabetes. According to WHO, in 2016, over 1.9 billion adults were overweight, of which, around 650 million people were obese. These devices allow the observation of blood glucose at various time intervals with the help of a sensor and these readings are transmitted over a wireless network. Respective readings are fed into diabetes management software to allow the patient to understand the disease better, in turn, helping them to manage it better.
Browse through Grand View Research's Medical Devices Industry Research Reports.
- Digital Diabetes Management Market - The global digital diabetes management market size was valued at 11.15 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2022 to 2030. The robust growth of the market is majorly attributed to the growing prevalence of diabetes, coupled with technological advancement and innovation. For instance, according to the International Diabetes Federation, approximately 536,600 adults were living with diabetes in 2021 and this number is expected to reach 783,700 in 2045.
- Preclinical Medical Device Testing Services Market - The global preclinical medical device testing services market size was valued at USD 2.3 billion in 2021 and is anticipated to exhibit a compound annual growth rate (CAGR) of 8.6% from 2022 to 2030. Demand for medical device testing services is being driven by escalating product complexity, and strict governmental regulations. However, one of the main factors propelling the market is the rising demand for technologically advanced medical devices.
Continuous Glucose Monitoring Device Market Segmentation
Grand View Research has segmented the global continuous glucose monitoring device market on the basis of component, end use, and region:
CGM Devices Component Outlook (Revenue, USD Million, 2016 - 2028)
- Transmitters
- Sensors
- Receivers
CGM Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)
- Hospitals
- Home Care
- Others
Regional Outlook (Volume, Million Units; Revenue, USD Million, 2016 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Market Share Insights
- November 2020: Medtronic announced FDA approval for its smart insulin pen called “InPen”, indicated for diabetic patients on multiple daily injections. The device comes with a Guardian CGM system, which enables real-time access to patients’ glucose and insulin data.
Key Companies profiled:
Some prominent players in the global Continuous Glucose Monitoring Device market include
- Medtronic
- Dexcom, Inc.
- Hoffmann-La Roche Ltd.
- Abbott
- Novo Nordisk A/S
- Ypsomed
- GlySens, Inc.
Order a free sample PDF of the Continuous Glucose Monitoring Device Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment